Internal Medicine · Beaver, PA
NPI
1154343556
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1211 3rd St
Beaver, PA, 15009
Phone (724) 770-0990
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
1,839 services
Medicare patients, 2024
248
Average age 76
Drug cost, 2024
$993K
13,507 prescriptions
Company payments, 2025
$1,697
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael S Heinle was code 99214 (office e&m - established), 439 times for 238 patients. In total Michael S Heinle billed 1,839 services in 30 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 439 | 238 | $73.70 | $32K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 147 | 130 | $10.78 | $1,584 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 96 | 96 | $122.57 | $12K |
| G0008 Administration of influenza virus vaccine | Office | 75 | 73 | $30.77 | $2,308 |
| 90662 Vaccine Product | Office | 71 | 69 | $81.12 | $5,760 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 29 | 15 | $47.38 | $1,374 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 26 | 22 | $210.17 | $5,464 |
| 96372 Injection Administration | Office | 17 | 14 | $9.46 | $161 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 13 | 11 | $34.23 | $445 |
By year: 2022 $76K for 1,651 services; 2023 $97K for 1,865 services; 2024 $81K for 1,839 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael S Heinle prescribed most often to Medicare patients was Atorvastatin Calcium, with 864 prescriptions and refills. In total Michael S Heinle wrote 13,507 Medicare prescriptions that cost $993K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 864 | 2,400 | 235 | $9,243 |
| Lisinopril Generic | 794 | 2,214 | 217 | $6,025 |
| Rosuvastatin Calcium Generic | 674 | 1,881 | 201 | $9,339 |
| Famotidine Generic | 611 | 1,593 | 190 | $12K |
| Carvedilol Generic | 567 | 1,435 | 138 | $6,492 |
| Levothyroxine Sodium Generic | 551 | 1,473 | 132 | $6,250 |
| Simvastatin Generic | 418 | 1,149 | 111 | $4,222 |
| Amlodipine Besylate Generic | 324 | 906 | 94 | $1,773 |
| Metformin Hcl Generic | 304 | 807 | 83 | $2,684 |
| Losartan Potassium Generic | 296 | 800 | 86 | $2,693 |
| Metformin Hcl Er Metformin Hcl | 287 | 777 | 91 | $5,948 |
| Tamsulosin Hcl Generic | 235 | 594 | 64 | $3,862 |
| Omeprazole Generic | 230 | 571 | 57 | $2,070 |
| Duloxetine Hcl Generic | 227 | 539 | 64 | $4,945 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 207 | 596 | 60 | $1,649 |
Brand drugs: 1,181 claims; generic drugs: 12,262 claims; opioid claims: 99.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael S Heinle $1,697 ($1,697 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $471.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $471 |
| Phathom Pharmaceuticals, Inc. PHAT | 4 | $259 |
| Novo Nordisk Inc NVO | 10 | $220 |
| Amgen Inc. AMGN | 11 | $175 |
| GlaxoSmithKline, LLC. GSK | 4 | $91.13 |
| Pfizer Inc. PFE | 4 | $90.73 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $52.81 |
| Eisai Inc. 4523.T | 2 | $49.18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49.03 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $36.07 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.